The first steps are pre-clinical toxicology and pharmacology analyses, where an experimental human protein product is tested in laboratory and animal studies.
After pre-clinical testing, the medicine can advance to clinical testing in human beings. Together with experts in the corresponding therapeutic areas, Octapharma's Clinical R&D teams design and execute highly regulated clinical trials that can take several years to complete.
Corporate clinical studies in different countries are managed by clinical research departments located in Austria and Switzerland, with support from US staff in case of Investigational New Drug (IND) studies.
Octapharma-sponsored clinical trials are registered in the US National Institute of Health Registry.